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Abstract: Aplysina is the best representative genus of the family Aplysinidae. Halogenated 
substances are its main class of metabolites. These substances contribute greatly to the 
chemotaxonomy and characterization of the sponges belonging to this genus. Due to their 
pharmacological activities, these alkaloids are of special interest. The chemistry of 
halogenated substances and of the alkaloids has long been extensively studied in terrestrial 
organisms, while the number of marine organisms studied has just started to increase in the 
last decades. This review describes 101 halogenated substances from 14 species of 
Aplysina from different parts of the world. These substances can be divided into the 
following classes: bromotyramines (A), cavernicolins (B), hydroverongiaquinols (C), 
bromotyrosineketals (D), bromotyrosine lactone derivatives (E), oxazolidones (F), 
spiroisoxazolines (G), verongiabenzenoids (H), verongiaquinols (I), and 
dibromocyclohexadienes (J). A compilation of their 
13C NMR data is also part of the 
review. For this purpose 138 references were consulted. 
Keywords: Aplysina; marine sponges; halogenated substances; 
13C NMR; review 
 





Marine sponges have been known and used by mankind since antiquity. They were included in the 
first classification of living organisms, written in 350 BC by Aristotle in Greece. At first thought to be 
plants, their animal nature was only recognized by the end of the XVIII century. However, great 
naturalists of the time such as Lamarck, Linnaeus and Cuvier classified them as Zoophytes. The 
elevation of the Porifera to the level of phylum was suggested by Huxley in 1875 and by Sollas in 
1884, and was only accepted at the beginning of the XX century [1]. 
Sponges belong to the phylum Porifera and are the most primitive of multicelled animals, having 
existed for roughly 700–800 million years. They have a very simple physiology of construction. They 
are aquatic organisms growing mostly in temperate salt waters but may also be found in fresh water. 
When reaching adult form, they are found in solid substrates in places that allow adequate conditions 
for their growth. Some, when in their primary states, may be mobile [2–4]. They are easily found in all 
marine environments, from the intertidal zones to the ocean depths of 8500 m in tropical and polar 
seas. Despite their wide distribution in terms of different oceans and depths, the rocky non-polluted 
coastline areas show greater populations of sponges which are also known for being rich in secondary 
metabolites [5–9]. 
The sponges are filtering animals, which utilize flagellate cells called coenocytes for promoting the 
circulation of the water through a system of canals existing in this phylum only called aquifer system, 
around which their body is built. This water flow brings organic particles and microorganisms which 
are filtered and eaten [10]. Of all the known sponges, only 1% grow in fresh water [11]. 
There are basically three classes of sponges, Calcarea (5 orders and 24 families), Desmospongiae 
(15 orders and 92 families) and Hexactinellida (6 orders and 20 families). So far, about 15,000 species 
of sponges have been described, their diversity however is believed to be much bigger than this [4,12]. 
Being sessile simple organisms, they evolved chemical defense mechanisms to protect themselves  
against predators and competitors, as well as against infectious microorganisms. Studies show   
that secondary metabolites in sponges carry out a crucial role in their survival in the marine   
ecosystem [13,14]. 
Because of their potential for the production of new substances of pharmacological interest, sponges 
have been one of the most chemically studied organisms. In the past 20 years, hundreds of substances 
have been isolated from them and many of those substances have already been identified, and present 
interesting biological and pharmacological (such as antibacterial, anticoagulant, antifungal, antimalarial, 
antituberculosis, antiviral, immunosuppressive and neuro-suppressor) activities [15–23]. The main 
reported activities for the Aplysina genus are antibacterial, antiyeast, antifungal, antiviral, cytotoxic 
and hyperglycemic activities, which can be seen in Table 1. 




Table 1. Bioactivities of marine sponges of the Aplysina genus. 
Activity/Species Name  Type of Extract  Bioassays Models, Organism, Dose or Route of Administration  Result  Ref. 
Antibacterial activity      
Aplysina archeri  MeOH Ext.  Agar plate-Bacillus subtilis; Escherichia coli-1.0 mg/Disc  Active  [24] 
Aplysina fistularis  MeOH Ext. 
MeOH-Toluene 
Chromatographic Fraction 
Agar plate-Bacillus subtilis; Escherichia coli 
Agar plate-Bacillus subtilis; Escherichia coli 
Agar plate-Staphylococcus aureus; Sarcinalutea; Klebsiella 
pneumonia; Proteus vulgaris; Bacteroides fragilis; Clostridium 







Aplysina lacunosa  MeOH Ext. 
MeOH Ext. 
Agar plate-Bacillus subtilis; Escherichia coli 





Aplysina laevis  Acetone Ext.  Agar plate-Bacillus subtilis; Escherichia coli  Active [27] 





ETOH (95%) Ext. 
 
Benzene Ext. 
Agar plate-Staphylococcus aureus-0.2µL/Disc 
Agar plate-Escherichia coli; Pseudomonas aeruginosa-0.2 µL/Disc 
Agar plate-Staphylococcus aureus-0.2 µL/Disc 
Agar plate-Escherichia coli; Pseudomonas aeruginosa-0.2 µL/Disc 
Agar plate-Staphylococcus aureus-0.2 µL/Disc 
Agar plate-Staphylococcus aureus; Escherichia coli; Pseudomonas 
aeruginosa-0.2 µL/Disc 





























ETOH (95%) Ext. 
 
Agar plate-Staphylococcus aureus; Escherichia coli; Pseudomonas 
aeruginosa-0.2 µL/Disc 
Agar plate-Staphylococcus aureus; Escherichia coli; Pseudomonas 
aeruginosa-0.2 µL/Disc 























Agar plate-Staphylococcus aureus; Escherichia coli; Pseudomonas 
aeruginosa-0.2 µL/Disc 








Antiyeast activity        
Aplysina archeri  MeOH Ext.  Agar plate-Saccharomyces cerevisiae-1.0 mg/Disc  Inactive  [24] 
Aplysina lacunosa  MeOH Ext.  Agar plate-Saccharomyces cerevisiae-1.0 mg/Disc  Weak 
Activity 
[24] 
Antifungal activity        
Aplysina archeri  MeOH Ext.  Agar plate-Penicillium atrovenetum-1.0 mg/Disc  Inactive  [24] 
Aplysina lacunosa  MeOH Ext.  Agar plate-Penicillium atrovenetum-1.0 mg/Disc  Inactive  [24] 
Antiviral activity        
Aplysina archeri  MeOH-Toluene Cell  culture-Virus-Feline Leukemia Active  [29] 
Cytotoxic activity        
Aplysina cauliformis  CHCl3-MeOH Ext. (1:1)  Cell culture-Cells-Cho K-1 Active  [30] 
Aplysina fistularis  MeOH Ext.   Cell culture-Leuk L-1210-ED50 50 mcg/mL  Active  [25] 
  MeOH-Toluene Cell  culture-CA-9KB Active  [26] 
  Chromatographic Fraction  Cell culture-Leuk L-1210-IC50 0.14 mcg/mL  Active  [26] 
Aplysina fulva  Isopropanol Ext.   Cell culture-CA-9KB < ED50 20 mcg/mL  Active  [31] 
  Isopropanol Ext.   Cell culture-Leuk L-1210 < ED50 20 mcg/mL  Active  [31] 
  Isopropanol Ext.   Cell culture-Leuk P-388 < ED50 20 mcg/mL  Active  [31] 
Aplysina lacunosa MeOH Ext.   Cell culture-Leuk L-1210-ED50 8.2 mcg/mL  Inactive  [25] 
Hyperglycemic activity      
Aplysina mollis ETOH (95%) Ext. Mouse-Intragastric-Dose 200 mg/kg  Active  [32] 
        




The pioneer investigative work in the field of sponge chemistry published by Bergmann and Feeney 
in the beginning of the 1950s led to the discovery of Cryptotethya crypta bioactive nucleosides 
spongothymidine and spongouridine [21]. These nucleosides were the basis for the synthesis of Ara-C, 
the first marine derivative anticancer agent, and antiviral drug Ara-A [22]. Today, Ara-C is used in the 
routine treatment of patients suffering from leukemia and lymphomas. One of its derivatives was also 
approved for use in patients with cancer of the pancreas, lungs and breast [23]. 
The Genus Aplysina 
The genus Aplysina, formerly known as Verongia and reclassified to Aplysina, is one of the richest 
in terms of secondary metabolites, described in 14 species of the family Aplysinidae, there are   
2 species from the Mediterranean Sea, 8 from the Caribbean, 3 from the Pacific Coast of Mexico and 
15 in the Brazilian coast. Of the above species, 8 have only been recently identified. From the 
Mediterranean Sea, the two described species of the genus Aplysina are: A. aerophoba (Schmidt, 1862) 
and A. cavernicola (Vacelet, 1959). From the Caribbean, among others we find A. fistularis insularis, 
A. fistularis form fulva, A. archeri, A. cauliformis and A. Lacunosa [33]. 
Like other genera of the order Verongida, Aplysina stands out for its unique biochemical 
characteristics. They show low terpene content, and possess a moderately high percentage of sterols, 
mostly within the aplystan skeleton. They also produce a significant series of brominated derivatives of 
tyrosine metabolites considered peculiar to species of this order. The sponges of this order are also 
known for their high phenotypic variability [34]. 
Marine organisms produce a cocktail of halogenated metabolites with potential commercial value. 
The structures found in these compounds go from linear chain acyclic, to complex polycyclic 
molecules [35,36]. The research of halogenated metabolites has been more focused on marine algae 
than on sea sponges [37–41]. Though many compounds have been discovered recently, many sponges 
species are poorly screened and the need for new drugs keeps this field open. 
In a previous paper our research group evaluated crude algae, sponge extracts and chemically 
determined molecules from Northeastern Brazil [42–48] with database survey [49–62]. 
In this paper we review halogenated substances from the genus Aplysina. A compilation of the  
13C NMR spectral data of the selected natural products is also provided. This type of genus and species 
investigation is helpful in the identification and capture of halogenated substances from the genus. 
2. Methodology 
An extensive bibliographic review was carried out to identify studies of halogenated substances 
isolated from the genus Aplysina. The present review covers the period of 1967 thru 2010. The search 
was performed using the following databases: NAPRALERT (Natural Products Alert at the University 
of Illinois, Chicago), Chemical Abstracts, and the Brazilian online scientific literature search system 
called “Periodical CAPES” (Coordination for the Improvement of Graduate Level Personnel). 
Tables 2 and 3 respectively show the halogenated substance distribution in the genus Aplysina, and 
the basic skeletons of those substances. Table 4 shows the different substituents for the diverse classes 
of halogenated substances. Table 5 describes the position of the substituents for the 101 substances 
isolated from each species. Finally Tables 6–14 show a compilation of 




Table 2. Distribution of the halogenated substances in the genus Aplysina. 
Species  Halogenated Substances  Substance Code  Nucleus Ref. 
A. aerophoba 
(Schmidt, 1862) 
Aeroplysinine 2  25  E1 [63] 
Aplysinadiene  26  E1 [64] 
(7S*,11R*)-5-[3,5-Dibromo-4-[(2-oxo-5-oxazolidinyl)]methoxyphenyl]-2-
oxazolidinone 
29  F1 [65] 
(R,R)-5[3,5-Dibromo-4-[(2-oxo-5-oxazolidinyl)] methoxyphenyl]-2-
oxazolidone 
31  F1 [64] 
Aerothionin  41  G1 [34] 
Homoaerothionin  47  G2 [66] 
Isofistularin-3  48  G2 [67] 
Aerophobin-1  76  G7 [68] 
2-(3,5-Dibromo-2-hydroxy-4-methoxyphenyl) acetamide  84  H [69] 
3,5-Dibromo-4-methoxyphenol  85  H [64] 
Methyl 2-(3,5-dibromo-2-hydroxy-4-methoxyphenyl) acetate  86  H [69] 
Dibromoverongiaquinol or dienone or  
3-5-dibromo-1-hydroxy-4-oxocyclohexa-2-5-diene-1-acetamide 
94  I1 [64] 





29  F1 [71] 
11,19-Dideoxyfistularin 3  33  G1 [72] 
Archerine  43  G1 [73] 
Fistularin-3  46  G2 [29] 
11-Ketofistularin 3  51  G2 [29] 
Aplysina compound 1 or 1-Oxa-2-azaspiro[4,5]deca-2,6-diene-3-carboxamide, 
N,N'-(2-oxo-1,4-butanediyl)bis[7,9-dibromo-10-hydroxy-8-oxo, [5R-
[5α(5'R*,9'R*,10'S*),9α,10β]]-(9CI) 
57  G4 [74] 




Table 2. Cont. 
A. archeri 
(Higgin, 1875) 
(+) Aeroplysinin 1  100  J [71] 





2-(3,5-Dibromo-4,4-dimethoxy-1-hydroxy-2,5-cyclohexadien-1-yl) acetamide  21  D1 [75] 
Caissarine C  42  G1 [76] 
Caissarine B  53  G2 [75] 
Agelocaissarine A1  58  G4 [76] 
Agelocaissarine A2  59  G4 [76] 
Agelocaissarine B1  60  G4 [76] 
Agelocaissarine B2  61  G4 [76] 
Caissarine A  79  G8 [75] 
A. cauliformis 
(Carter, 1882) 
2-(3,5-Dibromo-1-hydroxy-4,4-dimethoxycyclohexa-2,5-dienyl)acetamide  21  D1 [71] 
(7S*,11R*)-5-[3,5-Dibromo-4-[(2-oxo-5-oxazolidinyl)]methoxyphenyl]-2-
oxazolidinone 
29  F1 [71] 
11-Oxoaerothionin  52  G2 [77] 
Aplysinametabolite or Methyl 4-((5S,10R)-7,9-dibromo-10-hydroxy-8-
methoxy-1-oxa-2-azaspiro-[4.5]deca-2,6,8-trienecarboxamido)-2-
oxobutylcarbamate 
64  G7 [78] 
Methyl 4-((5S,10R)-7,9-dibromo-10-hydroxy-8-methoxy-1-oxa-2-azaspiro- 
[4.5]deca-2,6,8-trienecarboxamido)-3-oxobutylcarbamate or Aplysina 
compound 13 
65  G7 [78] 
Methyl-4-((5S,10R)-7,9-dibromo-10-hydroxy-8-methoxy-1-oxa-2-
azaspiro[4.5]deca-2,6,8-trienecarboxamido)butylcarbamate or Aplysina 
metabolite 14 
66  G7 [78] 
Aplysinamisine-1  67  G7 [30] 
Aplysinamisine-2  68  G7 [30] 
Aplysinamisine-3  69  G7 [30] 




Table 2. Cont. 
A. cavernicola 
(Vacelet, 1959) 
Cavernicolin-1  5  B1 [79,80] 
5-Bromo-7α-chlorocavernicolin  7  B2 [81] 
5-Bromo-7β-chlorocavernicolin  8  B2 [81] 
7β-Bromo-5-chlorocavernicolin  9  B2 [81] 
7α-Bromo-5-chlorocavernicolin  10  B2 [81] 
Monobromocavernicolin or 5-Bromocavernicolin  11  B2 [81] 
5-Chlorocavernicolin  12  B2 [81,82] 
7-Bromocavernicolenone  13  B3 [82] 
7-Chlorocavernicolenone  14  B3 [63] 
2-(3,5-Dibromo-1-hydroxy-4,4-dimethoxycyclohexa-2,5-dienyl) acetamide  21  D1 [63] 
Aeroplysinine 2  25  E1 [63] 
11,19-Dideoxyfistularin 3  33  G1 [63] 
12(R)-Hydroxy-11-oxoaerothionin  36  G1 [63] 
Aerothionin  41  G1 [63] 
Oxohomoaerothionin  44  G1 [63] 
11-Deoxyfistularin-3  45  G2 [63] 
Homoaerothionin  47  G2 [63] 
Isofistularin3  48  G2 [63] 
11-Oxoaerothionin  52  G2 [63] 
(+) 3-Bromo-5-chloroverongiaquinol or (+)-3-Bromo-5-chloro-1-hydroxy-4-
oxo-2,5-cyclohexadiene-1-acetamide 
91  I1 [81] 
(+) 3-Bromoverongiaquinol or (+)-3-Bromo-1-hydroxy-4-oxo-2,5-
cyclohexadiene-1-acetamide 
92  I1 [81] 
(DL) 5-Bromoverongiaquinol  93  I1 [81] 
Dichloroverongiaquinol  95  I1 [80] 








Aeroplysinine 2  25  E1 [83] 
A. fistularis 
(Pallas, 1766) 
Aplysamine1  1  A  [84] 
Aplysamine2  2  A  [84] 
Aplysfistularine  4  A [46] 
5-Amino-2,6-dichloro-4-hydroxycyclohex-2-enone acetic acid lactam  15  B4 [26] 
5-Amino-2-bromo-6-chloro-4-hydroxy-cyclohex-2-enone acetic acid lactam 
(5-bromo-7-chlorocavernicolin) 
16  B4 [26] 
5-Amino-2-6-dibromo-4-hydroxy-cyclohex-2-enone acetic acid lactam or 
Cavernicolin 
17  B4 [26] 
4,6-Dibromohomogentisamide  18  C  [85] 
3,5-Dibromohydroquinone-2-acetamide  19  C [86] 
2-(3,5-Dibromo-1-hydroxy-4,4-dimethoxycyclohexa-2,5-dienyl) acetamide  21  D1 [87] 
Aeroplysinine 2  25  E1 [88] 
(7S*,11R*)-5-[3,5-Dibromo-4-[(2-oxo-5-oxazolidinyl)]methoxyphenyl]-2-
oxazolidinone 
29  F1 [71] 
Aerothionin  41  G1 [88,89] 
Fistularin-3  46  G2 [88] 
Homoaerothionin  47  G2 [89] 
11-Oxoaerothionin  52  G2 [88] 
Purealidin-L  78  G7 [90] 
2-(3,5-Dibromo-2-hydroxy-4-methoxyphenyl) acetamide  84  H [26,69] 
2,6-Dibromo-1,4-benzoquinone  87  I1 [91] 
2,6-Dichloro-4-hydroxycyclohexa-2-5-dienone-4-acetamide  89  I1 [26] 








Dibromoverongiaquinol or dienone or 3-5-dibromo-1-hydroxy-4-
oxocyclohexa-2-5-diene-1-acetamide 
94  I1 [61–65,92–96] 




Cavernicolin-1  5  B1 [83,97] 
Cavernicolin-2  6  B1 [83,97] 
3,5-Dibromohydroquinone-2-acetamide  19  C [34] 
2’-(3,5-Dibromo-4-hydroxyphenyl) acetamide  20  C  [97] 
2-(3,5-Dibromo-1-hydroxy-4,4-dimethoxycyclohexa-2,5-dienyl) acetamide  21  D1  [97] 
Aeroplysinine 2  25  E1 [34] 
(7S*,11R*)-5-[3,5-Dibromo-4-[(2-oxo-5-oxazolidinyl)]methoxyphenyl]-2-
oxazolidinone 
29  F1 [97] 
11-Epi-fistularin-3  34  G1 [98] 
11-Hydroxyfistularin-3  35  G1 [99] 
12(R)-Hydroxy-11-oxoaerothionine  36  G1 [34] 
12(S)-Hydroxy-11-oxoaerothionine  37  G1 [34] 
Aerothionin  41  G1 [34,83,97] 
Fistularin-3  46  G2 [31,34,83,97] 
Homoaerothionin  47  G2 [34] 
11-Hydroxyaerothionin  50  G2 [34,97] 
11-Oxoaerothionin  52  G2 [34,97] 
Aplysinamisine-1  67  G7 [97] 
AraplysillinN
9-sulfamate  70  G7 [99] 
Fistularin-1  72  G7 [34] 
Fistularin-2  73  G7 [31] 
N-[5S,10R)-7,9-Dibromo-10-hydroxy-8-methoxy-1-oxa-2-azaspiro[4.5]deca-
2,6,8-triene-3-carboxy]-4-aminobutanoic acid 
74  G7 [99] 




Table 2. Cont. 
A. fulva 
(Pallas, 1766) 
Aerophobin-2  77  G7 [97] 
Aeroplysinin 1  100  J [34,66] 




Aerothionin  41  G1 [100] 
Homoaerothionin  47  G2 [101] 
Aplysinone A  54  G3 [101] 
Aplysinone D  55  G3 [101] 
Aplysinone B  56  G4 [101] 
Calafianin  62  G5 [100] 
Aplysinone C  63  G6 [101] 







32  F3 [74] 
11,19-Dideoxyfistularin 3  33  G1 [102] 
Aerothionin  41  G1 [74,103] 
Fistularin-3  46  G2 [74,102,103] 
Homoaerothionin  47  G2 [103] 
11-Dihydroaerothionin  49  G2 [102] 
11-Oxoaerothionin  52  G2 [102,103] 
Aplysina metabolite 14  66  G7 [74] 
14-Oxoaerophobin-2  75  G7 [102] 
Aerophobin-1  76  G7 [102] 
Aerophobin-2  77  G7 [102] 
(5S,10R)-Methyl 7,9-dibromo-10-hydroxy-8-methoxy-1-oxa-2-
azaspiro[4.5]deca-2,6,8-triene-3-carboxylate 
80  G9 [102] 









29  F1 [65] 
(7R*,11S*)-5-[3,5-Dibromo-4-[(2-oxo-5-oxazolidinyl)]methoxyphenyl]-2-
oxazolidinone 
30  F2 [71] 
11,19-Dideoxyfistularin-3  33  G1 [104] 
Aerothionin  41  G1 [104] 
Fistularin-3  46  G2 [104] 
11-Hydroxyaerothionin  50  G2 [104] 





98  I2 [27] 
(1'R,5’S,6'S)-2-(3',5'-Dibromo-1',6'-dihydroxy-4'-oxo-cyclohex-2'-enyl) 
acetonitrile 
99  I2 [27] 
(+) Aeroplysinin 1  100  J [27] 
A. species 
Aplysamine1  1  A  [84] 
Aplysamine2  2  A  [84] 
Aplyzanzine A  3  A [105] 
2-(3,5-Dibromo-4-ethoxy-1-hydroxy-4-methoxy-2,5-cyclohexadien-1-yl)-
ethanamide 
22  D2 [71,84,106] 
Aeroplysinine 2  25  E1 [106] 
(7R*,11S*)-5-[3,5-Dibromo-4-[(2-oxo-5-oxazolidinyl)]methoxyphenyl]-2-
oxazolidinone 
30  F2 [71] 
(R,R)-5[3,5-Dibromo-4-[(2-oxo-5-oxazolidinyl)]methoxyphenyl]-2-oxazolidone 31  F1 [106] 
11,19-Dideoxyfistularin-3  33  G1 [72] 
11-Oxofistularin-3  38  G1 [72] 




Table 2. Cont. 
A. species 
 
19-Deoxyfistularin-3  40  G1 [72] 
Aerothionin  41  G1 [107] 
Hemifistularin-3  71  G7 [72] 
(10R)-Ethyl-7,9-dibromo-10-hydroxy-8-methyl-1-oxa-2-azaspiro[4.5]deca-
2,6,8-triene-3-carboxylate 
81  G9 [106] 




Aplysinketal A  23  D1 [109] 
Aplysinketal B  24  D1 [109] 
Aplysinolide  27  E2 [109] 
Aplysinimine  28  E2 [109] 
(7R*,11S*)-5-[3,5-Dibromo-4-[(2-oxo-5-oxazolidinyl)]-methoxyphenyl]-2-
oxazolidinone 
30  F2 [109] 
Aerothionin  41  G1 [109] 
Homoaerothionin  47  G2 [109] 
2-(3,5-Dibromo-2-hydroxy-4-methoxyphenyl)-acetamide  84  H [109] 
2,6-Dibromo-4-acetamide-4-hydroxycyclohexadienone  88  I1 [109] 
Aplysina hydroxydienone or Dibromo compound 10  96  I1 [109] 
Aplysina hydroxydienoic methyl esther  97  I1 [109] 




Table 3. Basic skeletons of the halogenated substances isolated from sponges of the Aplysina. 



















Table 3. Cont. 
Bromotyrosineketals 
 
Code D1   
Code D2 



























































Table 4. Substituent groups of the halogenated substances. 
Bromotyramines 
 








































































































































Table 4. Cont. 
Spiroisoxazolines 
 







































































































Table 4. Cont. 
Verongiaquinols 











9  Nucleus 
1  Me  Me  -  -  -  -  -  -  -  A 
2  H  -  -  -  -  -  -  -  A 
3  H  -  -  -  -  -  -  -  A 
4  Me  Me  Me  -  -  -  -  -  -  A 
5  Br  H  Br  -  -  -  -  -  -  B1 
6  H  Br  Br  -  -  -  -  -  -  B1 
7  Cl  H  Br  -  -  -  -  -  -  B2 
8  H  Cl  Br  -  -  -  -  -  -  B2 
9  Br  H  Cl  -  -  -  -  -  -  B2 
10  H  Br  Cl  -  -  -  -  -  -  B2 
11  H  H  Br  -  -  -  -  -  -  B2 
12  H  H  Cl  -  -  -  -  -  -  B2 
13  Br  -  -  -  -  -  -  -  -  B3 
14  Cl  -  -  -  -  -  -  -  -  B3 
15  H  Cl  Cl  -  -  -  -  -  -  B4 
16  H  Cl  Br  -  -  -  -  -  -  B4 
17  H  Br  Br  -  -  -  -  -  -  B4 
18  OH  H  Br  OH  Br  -  -  -  -  C 
19  Br  OH  Br  H  OH  -  -  -  -  C 
20  H  Br  OH  Br  H  -  -  -  -  C 
21  Me  Me  -  -  -  -  -  -  -  D1 
22  Et  Me  -  -  -  -  -  -  -  D2 
23  Me  Butyl  -  -  -  -  -  -  -  D1 
24  Me  Pentyl  -  -  -  -  -  -  -  D1 
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26  H  Br  OH  Br  -  -  -  -  E1 
27  Br OMe  Br  H  -  -  -  -  E2 
28  Br OMe  H  Br  H  -  -  -  -  E2 
29    - -  -  -  -  -  -  -  F1 
30    - -  -  -  -  -  -  -  F2 
31    - -  -  -  -  -  -  -  F1 
32    - -  -  -  -  -  -  -  F3 
33 -  -  -  -  -  -  -  -  G1 
34 -  -  -  -  -  -  -  -  G1 
35 -  -  -  -  -  -  -  -  G1 
36 -  -  -  -  -  -  -  -  G1 
37 -  -  -  -  -  -  -  -  G1 
38 -  -  -  -  -  -  -  -  G1 
39  -  -  -  -  -  -  -  -  G1 
40 -  -  -  -  -  -  -  -  G1 
41    -  -  -  -  -  -  -  -  G1 
42 -  -  -  -  -  -  -  -  G1 
43 -  -  -  -  -  -  -  -  G1 
44 
 
-  -  -  -  -  -  -  -  G1 
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46 -  -  -  -  -  -  -  -  G2 
47    -  -  -  -  -  -  -  -  G2 
48 -  -  -  -  -  -  -  -  G2 
49 -  -  -  -  -  -  -  -  G2 
50 -  -  -  -  -  -  -  -  G2 
51 -  -  -  -  -  -  -  -  G2 
52  -  -  -  -  -  -  -  -  G2 
53  -  -  -  -  -  -  -  -  G2 
54    -  -  -  -  -  -  -  -  G3 
55    -  -  -  -  -  -  -  -  G3 
56    H Br  OH  H  Br  H  H  OH  G4 
57 Br  H  H  OH  H  Br  OH  H  G4 
58 H  Br  OH  H  Br  H  H  OH  G4 
59 Br  H  OH  H  H  Br  H  OH  G4 
60 H  Br  OH  H  Br  H  H  OH  G4 
61 Br  H  OH  H  H  Br  H  OH  G4 
62    -  -  -  - - - - -  G5 
63    -  -  -  - - - - -  G6 
64  -  -  -  - - - - -  G7 
65  -  -  -  - - - - -  G7 
66  -  -  -  - - - - -  G7 
67  -  -  -  - - - - -  G7 
68    -  -  -  - - - - -  G7 
69  -  -  -  - - - - -  G7 


































Table 5. Cont. 
71  -  -  -  - - - - -  G7 
72  -  -  -  - - - - -  G7 
73  -  -  -  - - - - -  G7 
74 
 
-  -  -  - - - - -  G7 
75  -  -  -  - - - - -  G7 
76    -  -  -  - - - - -  G7 
77  -  -  -  - - - - -  G7 
78    -  -  -  - - - - -  G7 
79  -  -  -  - - - - -  G8 
80  Me  -  -  -  - - - - -  G9 
81  Et  -  -  -  - - - - -  G9 
82    H -  -  -  -  -  -  -  H 
83 
 
OH -  -  -  -  -  -  -  H 
84 
 
OH -  -  -  -  -  -  -  H 
85 OH  H  -  -  -  -  -  -  -  H 
86 
 
OH -  -  -  -  -  -  -  H 
87  Br H  H  O  Br  -  -  -  -  I1 
88  Br  H OH  Br  -  -  -  -  I1 
89  Cl H  OH  Cl  -  -  -  -  I1 
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91  Br OH  OH  Cl  -  -  -  -  I1 
92  Br OH  OH  H  -  -  -  -  I1 
93  H OH  OH  Br  -  -  -  -  I1 
94  Br H  OH  Br  -  -  -  -  I1 
95  Cl H  OH  Cl  -  -  -  -  I1 
96  Br H  OH  Br  -  -  -  -  I1 
97  Br H  O  CH2CH2OCH3  Br  -  -  -  -  I1 
98  OH OH  -  -  -  -  -  -  -  I2 
99  OH OH  -  -  -  -  -  -  -  I2 
100  OH OH  CH2CN  -  -  -  -  -  -  J 
101  MeO OH  CH2CONH2  -  -  -  -  -  -  J 

















Table 6. Compilation of the 
13C NMR data of the halogenated substances from the genus 
Aplysina. Bromotyramines. 
Position  1  2  3  4 
1  140.3  140.3  137.94  138.58 
2  134.4  134.4  132.78  132.80 
3  118.7  118.7  117.74  118.02 
4  152.1  152.1  150.87  151.30 
5  118.7  118.7  117.74  118.02 
6  134.4  134.4  132.78  132.80 
7  35.2  35.2  34.20  32.26 
8  41.3  41.3  39.81  60.20 
9  -  165.8  170.82  - 
10  -  152.9  69.84  - 
11  -  28.7  31.57  - 
12  -  113.1  137.66  - 
13  -  134.7  133.21  - 
14  -  130.3  117.58  - 
15  -  155.8  152.34  - 
16  -  112.1  117.58  - 
17  -  131.7  133.21  - 
1’  71.7  71.7  69.71  71.00 
2’  26.4  26.4  25.38  26.79 
3’  56.9  56.9  55.41  55.77 











Table 7. Compilation of the 
13C NMR data of the halogenated substances from the genus 
Aplysina. Cavernicolins. 
Position  5  6  9  11  12  13  14 
1  184.0  184.0  183.4  188.91  188.89  80.90  82.7 
2  56.9  53.1  58.0  39.78  40.08  -  - 
3  68.7  64.7  67.9  58.60  58.56  168.30  171.4 
4  76.6  75.7  74.4  74.15  73.41  43.1  44.0 
5  149.9  149.0  146.3  150.07  145.84  69.5  69.5 
6  120.8  120.8  127.4  122.45  130.18  156.90  153.2 
7  43.0  45.1  42.4  43.58  43.78  118.80  129.5 
8  173.9  173.9  173.6  172.65  172.72  187.8  188.9 
9  -  -  -  -  -  46.6  47.6 




Table 8. Compilation of the 
13C NMR data of the halogenated substances from the genus 
Aplysina. Hydroverongiaquinols. 
Position  20 
1  130.0 
2  133.0 
3  111.0 
4  150.0 
5  111.0 
6  133.0 
2’  40.0 
3’  173.4 
Table 9. Compilation of the 
13C NMR data of the halogenated substances from the genus 
Aplysina. Bromotyrosineketals. 
Position  22  23 
1  71.3  123.55 
2  140.3  123.55 
3  124.1  142.11 
4  96.7  71.92 
5  124.1  142.11 
6  140.3  123.55 
7  44.2  45.03 
8  173.2  172.99 
9  51.3  51.04 
10  60.2  63.98 
11  15.4  32.34 
12  -  20.04 
13  -  14.10 
14  -  - 
Table 10. Compilation of the 
13C NMR data of the halogenated substances from the genus 
Aplysina. Bromotyrosine Lactone Derivatives. 
Position  25  26  27  28 
1  89.1  148.85  154.29  161.3 
2  135.5  109.12  100.74  106.7 
3  119.3  103.75  161.97  155.2 
4  151.2  147.16  111.80  110.8 
5  107.6  103.75  125.75  135.2 
6  77.0  113.68  122.35  117.0 
7  42.2  146.35  117.53  40.6 
8  173.7  165.91  165.23  164.0 
9  -  144.60  -  - 
10  -  128.12  150.75  - 
11  -  128.12  25.21  - 
12  -  19.79  23.69  - 




Table 11. Compilation of the 
13C NMR data of the halogenated substances from the genus 
Aplysina. Oxazolides. 
Position  29  30  31  32 
1  153.5  151.6  142.3  140.45 
2  119.3  117.6  118.2  118.63 
3  131.9  130.7  130.8  131.45 
4  140.6  138.9  140.0  152.60 
5  131.9  130.7  130.8  131.45 
6  119.3  117.6  142.3  118.63 
7  76.3  74.3  54.3  75.78 
8  47.9  46.9  47.0  48.42 
9  159.8  158.5 or 158.2  157.8  159.05 
10  75.0  73.0  53.0  72.05 
11  75.5  73.5  53.55  
12  41.7  41.1  41.47  46.97 
13  160.2  161.35  158.4  161.35 
MeO  -  -  -  50.25 
Table 12. Compilation of the 
13C NMR data of the halogenated substances from the genus 
Aplysina. Spiroisoxazolines. 
Position  33  34  35  36  37  38  39  40  41 
1  75.28  75.0  75.42  75.47  75.47  75.29  75.11  75.09  75.5 
2  122.07  122.0  122.74  114.14  114.14  122.11  122.11  122.10  114.2 
3  148.77  148.6  149.28  149.28  149.28  148.82  148.73  148.75  149.3 
4  113.81  113.7  114.16  122.78  122.78  113.85  113.85  113.78  122.7 
5  132.37  132.0  132.24  132.23  132.23  132.24  132.27  132.28  133.2 
6  91.67  91.8  92.48  92.64  92.64  90.04  91.95  91.56  92.6 
7  40.13  39.8  40.13  40.09  40.09  39.99  39.87  40.03  40.1 
8  155.24  154.9  155.27  155.12  155.12  154.80  154.79  155.14  155.5 
9  160.07  160.4  161.81  161.93  161.93  160.29  160.24  160.00  161.6 
1'  75.28  75.1  75.42  75.47  75.47  75.29  75.18  75.20  75.5 
2'  122.07  122.1  122.74  114.14  114.14  122.11  122.11  122.10  114.2 
3'  148.77  148.6  149.28  149.28  149.28  148.82  148.74  148.75  149.3 
4'  113.81  113.7  114.16  122.78  122.78  113.85  113.85  113.78  122.7 
5'  132.30  132.1  132.16  133.21  133.21  132.23  132.28  132.28  133.2 
6'  91.67  91.8  92.48  92.54  92.54  91.86  91.59  91.76  92.6 
7'  40.09  39.9  40.04  40.03  40.03  39.89  40.09  40.08  40.1 
8'  155.14  155.0  154.12  154.92  154.92  155.16  155.16  155.16  155.5 
9'  160.01  160.5  161.55  161.80  161.80  160.48  160.03  160.41  161.6 
10  37.47  43.4  37.94  49.87  49.87  47.52  47.46  43.49  38.4 
11  30.55  69.7  30.59  207.84  207.84  200.82  200.87  69.68  26.1 
12  72.16  75.7  71.61  75.73  75.73  76.52  76.48  75.79  26.1 
13  152.30  152.5  153.56  43.43  43.43  151.93  151.23  151.97  38.4 
14  118.48  118.3  118.99  -  -  118.11  118.07  118.31  - 
15  134.06  131.3  131.69  -  -  131.55  134.21  134.14  - 
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17  134.06  131.3  131.69  -  -  131.55  134.21  134.14  - 
18  118.48  118.3  118.99  -  -  118.11  118.07  118.31  - 
19  34.75  71.3  72.18  -  -  71.46  34.74  34.71  - 
20  40.96  47.5  47.63  -  -  47.60  40.85  40.91  - 
MeO  60.21  60.2  60.35  60.39  60.39  60.23  60.19  60.19  60.4 
Position  42  43  44  45  46 49 50 51  52 
1  72.4  75.41  75.50  74.60  74.73  73.55  73.8  74.67  73.55 
2  119.6  114.24  120.80  121.66  121.80  120.81  121.4  121.85  120.88 
3  145.9  149.29  149.31  147.92  148.06  147.15  147.7  148.06  147.13 
4  111.9  122.75  114.15  115.16  115.20  113.09  113.1  115.20  113.08 
5  130.1  132.30  131.32  132.15  132.36  131.25  130.6  132.30  131.20 
6  89.0  92.39  92.63  91.72  91.87  90.32  91.9  91.87  90.50 
7  38.5  40.26  40.21  40.27  40.30  42.53  38.7  40.30  39.70 
8  153.3  155.34  155.29  155.10  155.17  154.47  153.9  155.18  154.37 
9  157.4  161.44  161.81  160.05  160.52  158.98  160.0  160.46  159.11 
1'  72.4  75.51  75.50  74.67  74.73  73.55  73.8  74.67  73.55 
2'  119.6  114.24  120.80  121.66  121.80  120.81  121.3  121.85  20.84 
3'  145.9  149.29  149.31  147.92  148.06  147.15  147.7  148.06  147.11 
4'  111.9  122.75  114.15  115.16  115.20  113.09  113.1  115.20  113.08 
5'  130.1  132.30  132.25  132.31  132.36  131.25  130.6  132.30  131.20 
6'  88.9  92.45  92.36  91.78  91.93  90.32  91.8  91.13  90.24 
7'  38.5  40.26  40.04  40.27  40.30  42.53  38.7  40.16  39.45 
8'  153.4  155.41  154.93  155.23  155.25  154.47  153.9  154.77  154.05 
9'  157.4  161.57  161.81  160.44  160.52  158.98  160.0  160.56  158.86 
10  44.2  39.07  49.17  37.13  43.95  39.04  36.2  47.49  48.52 
11  67.2 
(65.7)
c 
33.92  206.18  30.37  69.47  71.04  68.0  201.34  204.43 
12  30.6  33.51  37.57  71.51  76.13  71.04  45.0  76.32  38.59 
13  24.0  135.87  24.11  152.27  152.29  39.02  33.6  151.22  33.82 
14  35.0 
(32.5)
c 
150.68  39.61  118.35  118.42  -  -  118.06  - 
15  -  111.32  -  130.90  131.09  -  -  131.10  - 
16  -  126.67  -  143.35  143.52  -  -  144.23  - 
17  -  149.52  -  130.90  131.09  -  -  131.10  - 
18  -  126.09  -  118.35  118.42  -  -  118.06  - 
19  -  23.09  -  70.70  69.47  -  -  70.70  - 
20  -  30.10  -  47.99  48.15  -  -  48. 01  - 
21  -  40.03  -  -  -  -  -  -  - 
MeO 58.4  60.44  60.38  59.75  59.86 59,63  60.0  59.86  59.63 
Position  53  54  55  56  57 58 59 60  61 
1 74.1  75.3  75.2  75.0  74.73  74.5 74.0 74.5  68.5 
2 113.5  113.9  113.9  57.4  57.11  57.2 55.0 57.2  54.6 
3 147.6  148.7  148.7  183.7  183.51  184.1 184.1 184.2  183.0 
4 121.2  122.0  122.0  122.5  122.45  122.7 123.0 122.7  123.2 
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5 131.7  132.4  132.4  149.5  149.09  149.3 146.2 149.4  146.3 
6 90.7  91.5  91.5  91.4  91.67  91.5 90.5 91.4  90.5 
7 40.0  40.3  40.2  38.6  38.24  38.2 41.4 38.2  41.4 
8 155.0  155.4  155.3  154.9  154.53  154.8 155.5 154.8  155.5 
9 159.3  159.9  159.9  159.7  159.76  160.1 160.1 160.1  159.7 
1' 74.1  75.1  75.0  75.0  74.78  74.5 74.0 74.5  68.5 
2' 113.5  57.4  57.5  57.4  57.07  57.2 55.0 57.2  54.6 
3' 147.6  183.7  183.7  183.7  183.51  184.1 184.1 184.2  183.0 
4' 121.2  122.5  122.5  122.5  122.36  122.7 123.0 122.7  123.2 
5' 131.7  149.5  149.5  149.5  149.17  149.3 146.2 149.4  146.3 
6' 90.7  91.5  91.5  91.4  91.42  91.5 90.5 91.4  90.5 
7' 40.0  38.6  38.6  38.6  38.10  38.2 41.4 38.2  41.4 
8' 155.0  154.9  154.9  154.9  154.27  154.8 155.5 154.8  155.5 
9' 159.3  159.7  159.7  159.7  159.64  160.1 160.1 160.1  159.7 




29.7  27.5  29.7  204.70  68.8 68.8 70.3  70.3 
12 32.2  24.7  27.5  24.7  39.63  34.6 34.6 32.4  32.4 
13 25.5  29.7  39.5  29.7  34.78  37.0 37.0 26.0  26.0 
14 36.6  39.7  -  39.7 -  -  -  37.0 37.0 
15  34.4  -  -  -  - - - -  - 
16  39.4  -  -  -  - - - -  - 
MeO  60.1  60.2  60.2  -  - - - -  - 
Position 62  63  64  65  66  67  68  69  70 
1 56.9  75.3  73.55  73.56  73.57 75.45 73.44 75.40  73.6 
2 53.0  113.8  120.80  120.79  120.86 122.68 120.64 122.72  120.8 
3 186.0  149.0  147.13  147.12  147.16 149.23 147.07 149.23  147.3 
4 122.8  122.0  113.04  113.04  113.11 114.12 113.00 114.10  113.1 
5 143.7  132.4  131.19  131.21  131.23 132.21 131.22 132.14  131.2 
6 84.0  91.5  90.16  90.24  90.52 92.39 90.12 92.55  90.2 
7 43.6  40.2  39.50  39.50  39.33 40.19 39.50 40.06  39.3 
8 154.9  155.3  154.34  154.34  154.08 155.32 154.44 155.11  154.3 
9 158.3  159.3  158.37  158.87  159.13 161.33 158.82 161.61  158.9 
1' 56.9  58.1  - -  -  -  -  -  - 
2' 53.0  54.2  - -  -  -  -  -  - 
3' 186.0  186.0  - -  -  -  -  -  - 
4' 122.8  124.1  - -  -  -  -  -  - 
5' 143.7  144.1  - -  -  -  -  -  - 
6' 84.0  85.3  - -  -  -  -  -  - 
7' 43.6  44.5  - -  -  -  -  -  - 
8' 154.9  155.6  - -  -  -  -  -  - 
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10 38.6  39.8  33.83  49.89  48.58 39.49 38.53 37.86  36.2 
11 26.4  29.7  38.29  205.66  205.75 123.47  28.23  30.76  29.4 
12 26.4  24.7  205.66  38.29  39.75 122.33 23.28  72.30  71.2 
13 38.6  29.7  49.89  33.83  35.21 130.81 27.99 153.61  150.8 
14 -  39.7  156.98  156.98  157.03 151.45  40.65  118.94  117.0 
15 -  - - -  -  118.11  157.20  131.66  133.0 
16 -  - - -  -  -  -  142.82  140.6 
17 -  - - -  -  -  -  131.66  133.0 
18 -  - - -  -  -  -  118.94  117.0 
19 -  - - -  -  -  -  71.64  33.7 
20 -  - - -  -  -  -  47.62  44.7 
21 -  - - -  -  -  -  173.29    - 
22 -  - - -  -  -  -  47.62  - 
23 -  - - -  -  -  -  22.68  - 
MeO-C3 -  60.2  59.60  59.60  59.79 60.42 59.56 60.42  59.6 
MeO-C14 -  -  51.54  51.54  51.28  -  -  -  - 
Position  71 74 75 76 79 80 81 
1  75.21 73.4  75.5 73.57 76.4  76.3  75.1 
2  122.15  120.8 114.1  120.87  115.1 114.9 113.8 
3  148.78  147.0 149.3  147.18  150.2 150.1 149.0 
4  113.90  113.3 122.8  113.08  123.7 123.5 122.3 
5  132.27  131.2 132.3  131.21  133.2 133.0 132.3 
6  91.84 90.1  92.3 90.33 93.4  93.2  92.6 
7  40.08 39.7  40.2 39.26 41.0  40.1  40.0 
8  155.14  154.8 155.3  154.37  156.0 159.5 153.3 
9  160.42  158.9 161.6  159.10  162.8 162.5 161.0 
10  47.71 39.4  39.9 37.66 44.7  40.5  63.0 
11 71.43  24.5 29.8  24.12    78.4  -  14.4 
12 138.5  34.5 25.6  130.79  25.7  -  - 
13 111.38  174.7 61.9  133.84  40.2  -  - 
14  130.90  - 190.6  116.21  157.5 -  - 
15  150.72  - 171.4 -  -  -  - 
16  111.38  - - - - - - 
17  130.90  - - - - - - 
MeO-C3  60.22 59.6  60.4 59.63 61.3  59.2  60.8 
Although the isoxazoline alkaloids are the group with more 
13C NMR data, some chiral centers of 
this group continue with an undefined stereochemistry due to the incompatibility of using X-ray 
crystallography techniques, possessing sometimes non-crystalline characteristic [98]. Some positions 
with 
13C NMR data had to be revised because there were mistakes in the numbering of the carbon 




Table 13. Compilation of the 
13C NMR data of the halogenated substances from the genus 
Aplysina. Verongiabenzenoids. 
Position  82  83 
1  154.87  152.19 
2  111.18  117.30 
3  134.63  133.35 
4  129.20  135.92 
5  130.33  133.35 
6  117.68  117.30 
7  29.07  26.88 
8  68.51  65.07 
OMe  59.88  60.31 
(Me)3N
+  53.77  52.23 
Table 14. Compilation of the 
13C NMR data of the halogenated substances from the genus 
Aplysina. Verongiaquinol. 
Position 90  97  98 
1  172.6  183.0  183.0 
2  119.9  122.7  123.7 
3  153.2  151.7  146.6 
4  70.8  75.5  74.2 
5  148.8  78.4  78.9 
6  127.6  56.1  57.1 
1'  -  116.9  116.9 
2'  -  28.4  28.4 
CH2  45.1  -  - 
CONH2  169.4  -  - 
Table 15. Compilation of the 
13C NMR data of the halogenated substances from the genus 
Aplysina. Dibromocyclohexadiene. 
Position 101 
1  86.3 
2  109.1 
3  149.7 
4  113.6 
5  140.4 
6  76.5 
7  42.1 
8  172.8 
9  60.2 
10  60.3 
3. Discussion 
The genus Aplysina belongs to the order Verongida, sponges with a wide variety of metabolites. 
Sterols [110,111], carotenoids [112], amino acids [113] and rare fatty acids [114] have all been 




isolated from this order. However, the peculiarity of this order is from the ecological and medicinal 
points of view, in that great production of halogenated substances originates from the metabolism of 
amino acids such as phenylalanine and tyrosine. 
The halogenated substances found in the marine sponges of the genus Aplysina can be classified as: 
(A) Bromotyramines, (B) Cavernicolins, (C) Hydroverongiaquinols, (D) Bromotyrosineketals,  
(E) Bromotyrosine lactone derivatives, (F) Oxazolidones, (G) Spiroisoxazolines,   
(H) Verongiabenzenoids, (I) Verongiaquinols and (J) Dibromociclohexadiens. 
3.1. Chemotaxonomy Importance of Aplysina Sponges 
Although in the past, it was suspected that bromotyrosine compounds were not present in Brazilian 
Aplysina species [69], nowadays numerous studies have shown the presence of these chemical 
biomarkers, not only in Brazilian species, but in almost all the Verongida order. 
In order to classify the large number of halogenated compounds reviewed in Table 2, for each 
sponge species, we listed the halogenated compounds under the correlated species. Considering the 
taxonomic species diagnosis of morphologic variation of spongin fibers is difficult [33], chemical 
composition can be used as a tool for a more accurate identification. The distribution of the 
halogenated compounds is widespread in Aplysina  genre, and studies show that mainly 
bromoisoxazoline alkaloids have been found in almost all species. This family of metabolites was 
usefully employed as a chemical marker for the distinction of some taxa as Aplysina aerophoba and 
Aplysina cavernicola, two very physically similar species [63], but biochemically different. In another 
situation, majority of aerothionine was key to identify two subspecies of A. fistularis, which split into 
A. fulva and A. insularis [115]. 
The similarity between agelorins A and B, isolated from Agelas oroides and produced by   
Aplysina caissara, was essential to show the two genera, Aplysina and Agelas, have a phylogenetic 
relationship [76] and 11-epi-fistularin-3 was yielded by Aplysina fulva [98]. 
The presence of stereo metabolites isolated from Aplysina sponges as derivatives of fistularin-3 
discussed by Rogers et al., 2005 [98], provides evidence that enzymatic pathways are   
non-stereoselective in these sponges. 
As can be seen, each kind of genus adds a different profile of metabolites. However, even with a 
different chemical profile, Aplysina sp. has compounds that give a clue to their evolutionary origin. 
3.2. Bromotyramines 
The substances aplyzanzine A, aplysamine-1 and aplysamine-2 present a dibromotyramine 
structural portion, and probably originated in accordance with Evan et al. [82], by amidation with other 
bromotyrosinated radicals. Moloka’inamine [116] and purealidin C isolated from Psammaplysilla 
purea  [90] are examples of metabolites isolated from sponges of the order Verongida, having 
dibromotyramine in their structures. According to Carney, free phenolic groups are important 
precursors nitrile phenolic [96], hence the similarity between methoxylated compound, aplysamine-2, 
and hydroxylated analogue, psammaplin-A [84], observed by Xynas and Capon, 1989, shows that 





Figure 1. Metabolism of the bromotyrosine derived metabolites (  For the steps clarified 































Cavernicolines are γ and δ-lactames formed by a residual halogenated tyrosine precursor [81] and 
also having a bi-cyclic system. The junction of the rings occurs in carbons C-3 and C-4 in ortho 
position, while in the 7-bromocavernicolenone and in the 7-chlorocavernicolenone, this junction 
occurs in carbons C-2 and C-4. They can be defined as haloperoxidases with the role of converting 
either the 3-chloro (V)  ortho 3-bromotyrosine (IV)  in residues of 3,5-dichloro (VIII) or   
3,5-dibromotyrosine (VI) or 3-chloro-5-bromotyrosine (VII) or 3-bromo-5-chlorotyrosine (IX), 
respectively [80]. These substances have a chiral center at C-2 and their R and S enantiomers are 
obtained in racemic mixtures, or relatively pure from the genus Aplysina. In the formation of 
cavernicolines, as to the substitution pattern (ortho or para) it is suggested that the biosynthesis 
pathway has either a halo-tyrosine (XV, XVI, XVIII and XVIX) or a halo-dopa (XIV and XVVI) 
intermediary which will form a spirolactone precursor (XXII and XXIII), allowing the formation of 
intermediaries in racemic or quasi-racemic mixtures. The absence of control in the absolute 
stereochemistry of this class is intrinsic to phenol oxidative coupling [81,117]. It is noteworthy that 
experimental observations [118] show that 3,5-dibromo-4-methoxyphenylalanine methyl ester (XX) in 
reaction in an anodic oxidative medium form a more appropriate intermediary (XXI) than the 
spirolactone, originating derivatives similar to the stereoisomers of the cavernicolines with 
considerable yields (See Figure 1). 
3.4. Hydroverongiaquinols 
The hydroverongiaquinols are 2,6-bromotyrosine phenolic derivatives. Both the hydroverongiaquinols 
and the verongiabenzenoids are important mediators in biosynthesis of other classes of bromotyrosine 
metabolites. The verongiabenzenoids are part of the biosynthesis of isoxazoline alkaloids, and 
hydroverongiaquinols are important precursors in the formation of metabolites which need free 
phenolic groups to convert themselves into α-oximine substances, such as the phenolic nitriles. However, 
phenolic nitriles have not been found in the genus Aplysina, they are found in the genus Ianthella 
where substances like the bastadins, are important chemotaxonomic markers for the genus [119]. 
3.5. Bromotyrosineketals 
The bromotyrosineketals have a 3,5-dibromocyclohexa-2,5-dienyl ketal skeleton system. Literature 
shows that the dimethoxy and methoxy-ethoxy ketals (XXXII) isolated from Aplysina fistularis and 
from Aplysina cauliformis [92,93,120], are artifacts formed by the oxidation of dienone, since the 
dimethoxy form is obtained as a mixture of diastereoisomers [94,95], both showing antibacterial 
activity. Further evidence that they are artifacts is the formation of dimethoxy and methoxy-ethoxy 
ketals which can be explained as being formed from an arene (dienone intermediary XII), which 
suffers 1,4 additions of methanol, water or ethanol (Figure 2), and displayed a reaction described by 
Kasperek et al. [94,95,121]. However, the methoxy-butoxy and methoxy-pentoxy ketals isolated from 
Aplysina thiona [109] are not considered reaction products. Aplysinketal A was isolated only in the 
form of diastereoisomers, and the absence of the dimethoxy ketal indicates the non-existence of 
reactions during the extraction process [109]. It has been suggested that the formation of the C4 and C5 




Figure 2. Spiroisoxazoline and acetal formation as production artefacts. 
 
3.6. Bromotyrosine Lactone Derivatives 
The bromotyrosine lactone derivatives, with the exception of aplysinimine which is an imine, are 
five member lactones condensated with 3,5-dibromotyrosine residues (XXIV). Aeroplysinin-2 is different 
from the others because it has a cyclodiene group instead of an aromatic ring, while aplysinadiene 
presents a cis-trans diene side chain. It is proposed that the biosynthesis of this class of substances has 
an imine-ether (XXXIV) as initial intermediary, a hydroxylated derivative of aplysinimine. This 
derivative will either suffer a tertiary alcohol dehydration to form aplysinimine [109,120] or will 
follow other biosynthetic pathways similarly to bromotyrosine lactones as aeroplysinin-2, or the 
verongiabenzenoids and verongiaquinols, in this case the intermediary suffers dehydroxylation and 
demethylation and can form artifacts such as dimethoxys and methoxy-ethoxy ketals. [122]. Aplysinolide 
is considered an artifact, since it possesses an α,β-unsaturated side chain which is uncommon to find 
linked to a lactone ring. In accordance to Cruz et al. [109] this substance can be formed by combining 





Oxazolidones are very common in Aplysina, but just two types are found: diastereoisomers of 
bisoxazolidone and methoxy derivative. This derivative presents two chiral centers with different 
stereochemistries for different species. Studies show that these bisoxazolidone’s isomers have a 
relative configuration of 7S*, 11R* [97] and 11R*, 7S* [106], as determined by comparison with 
bisoxazolidone isolated from Ascidia Clavelina oblonga [123] and an absolute configuration R, R [64] 
obtained by X-ray crystallography. There are evidences that fistularin-3 degradation promotes 
bisoxazolidone and aeroplysinin-1 production [13]. 
3.8. Spiroisoxazolines 
The spiroisoxazolines also known as isoxazoline alkaloids form the biggest group of   
Aplysina and Verongid order metabolites. They are divided into two structure types:   
mono-spirocyclohexadienylisoxazolines and bis-spirocyclohexadienylisoxazolines [124]. 
The chemical structure of mono-spirocyclohexadienylisoxazolines (nuclei G7, G8) have essentially one 
spirocyclohexadienylisoxazoline ring bonded to a 1–6 carbon side chain with exception of the 
spiroisoxazoline acid ester (nucleus G9) [83] considered an artifact of ethanolic condensation from 
spiroisoxazoline acid [125]. The bis-spirocyclohexadienylisoxazolines (nuclei G1, G2) can present the 
same ring, which in the more common example is bonded to a 3–11 carbon side chain.  
This side chain is bonded to another spirocyclohexadienylisoxazoline ring [124]. In other 
spiroisoxazolines, the rings suffer oxidation of the methoxy group forming a cyclohexenone (nuclei 
G3, G4) [74,76,101]. Cyclohexenone also suffers hydroxyl or bromine oxidations originating 
cyclohexenone epoxide between carbons 1 and 2 and forming oxaspirocyclohexenonylisoxazolines 
(nuclei G5, G6) [100] 
The biosynthetic pathway for spiroisoxazolines needs tyrosine intermediates with O-methyl groups 
(XXVII), which are metabolized to form oxime grouped intermediates (XXVIII) and shortly thereafter 
form other intermediaries with arene oxide (XXIX). The nucleophilic attack of the oxime over either 
the epoxide or the phenol originates by breaking the epoxide which forms the isoxazole ring (XXX) [96]. 
The C4 or C5 side chains that extend out of the ring such as in aerothionin and inhomoaerothionin are 
produced via ornithine and lysine respectively (Figure 2) [70,94,95,126]. However, when the side chains 
present a 4-aminobutanoic substituent it is suspected that the amino acid involved is glutamic acid 
(Figure 2) [99]. In some spiroisoxazolines such as fistularin-3, and araplysillin N
9-sulfamate, there is a  
3-amino-1-propanol connector which binds itself to other structures and probably has as a precursor of its 
biosynthesis a decarboxylated product of the uncommon amino acid, homoserine. This amino acid is an 
intermediary for the enzyme S-adenosylmethionine (SAM). It is suggested that the SAM is involved in SN2 
substitutions of hydroxyl of 3,5-dibromotyrosine (DBT) (XXIV), making it susceptible to the formation of 
methoxyl groups by methyltransferase and O-alkylated bonds via other enzymes. The enzyme responsible 
for  O-alkylations is putative C
3-alanil-methyltransferase which allows 3-amino-1-propanol connector 
bonding to the DBT residue, forming spiroisoxazoline residue complexes with large molecular masses 
(XXV) which are then incorporated in the isoxazoline rings [99]. The alkaloid archerine, a dimer of two 




In sponges of the order Verongida, the spherule cells have the capacity of stocking and secreting 
isoxazoline alkaloids, which are modified by enzymes located in distinct locations [127,128]. The 
extracts of the majority of the sponges belonging to the genus Aplysina, when tested, show that their 
enzymes convert brominated isoxazoline alkaloids into aeroplysinin-1 and dienones. Sponges of other 
orders are unable to perform this biotransformation [129]. Puyana et al. [130] demonstrated that there 
is no aeroplysinin-1 and dienones production when there is a decrease in the amount of 
spiroisoxazolines. The ecological function of this enzymatic activation is microbial pathogen growth 
inhibition and the repellent odor, which decreases the predatory search by fishes [129]. 
Although the agelocaissarines A1, A2, B1 and B2 were initially considered production artifacts as 
pairs of stereoisomers, this was later modified by the observation of in vitro experiments showing the 
absence of substances with relative stereochemistries different to those found in the work [76]. 
In therapeutics these substances demonstrate tumor cell cytotoxic [22], antimicrobial [15] and 
antihistamine [73] activity. 
Spiroisoxazolines vary in different species, but also inside the single species. While A. fulva 
produces aerothionin as its major component (0.11%) [34], this same substance is not present in   
A. insularis [74] and in A. fulva it appears with a larger amount (0.52%) [102]. Nuñez et al. [97], 
affirms that this chemical variation may be due to either different extraction and isolation techniques, 
or to biological diversity of the areas in which the sponges are collected. This chemical distinction led 
to reinforce the hypothesis that Aplysina aerophoba and Aplysina carvernicola have metabolic 
differences and that A. aerophoba, erroneously identified in the work of Cimino et al. [67], was in fact 
Aplysina cavernicola. 
The presence of hemi-fistularin, isolated together with 11-oxofistularin-3, begs us to question 
whether the first is a precursor of 11-oxofistularin-3 biogenesis, or a degradation product [72]. 
Fistularin-3 shows another type of variability. Besides having stereoisomers of (+) fistularin-3, such as 
(+)-isofistularin-3 and 11-epi-fistularin-3, the chemical composition of sponges contains them in 
irregular proportions, which makes it difficult to determine through optical rotation. In order to 
determine the absolute configuration of fistularin-3 and its stereoisomers, a microscale analysis with 
Marfey’s reagent, has been used that led to the formation of stable reaction products analyzed by  
LC-MS [98]. 
3.9. Verongiabenzenoids 
The verongiabenzenoids are aromatic methoxylated substances which present a skeleton with a  
2,6-dibromomethoxybenzene nucleus. Biogenetically methoxylated, some verongiabenzenoids can 
form isoxazolines [13] or epoxide intermediaries from the arene oxide, which leads to forming other 
verongiabenzenoids [96]. 
3.10. Verongiaquinols 
The chemical structure of the verongiaquinols is either a cyclohexadien-2-one or   
cyclohexadien-2,6-one system, with either bromine or chlorine substituents in positions 2 and 6 and 
hydroxyls on carbons C-3 and C-4. They also may suffer ramifications on carbon C-4. The 




dienone (XII). The degradation of bromotyrosine substances such as iso-fistularin-1 and aerophobin-2 
after mechanical injury led to the formation of aeroplysinin-1 (XXXII) and (XII). It is also noteworthy 
that the extraction of frozen sponges and consequent exposure to alkaline sea water will form dienones 
(XII) [97,130,131]. Besides being integrated at the metabolic level, dienone and aeroplysinin-1 have 
an important defense role for sponges: cytotoxic, algicidic, molluscicide and antibacterial activity have 
been reported [131,132]. 
Other verongiaquinols such as 2,6-dibromoquinone have been reported to inhibit the enzyme RNA 
polymerase II, blocking the initiation of the chain, but not its elongation [133]. 
It is not known for sure if (1'R,5'S,6'S) and (1'R,5'R,6'S)-2-(3'-5'-dibromo-1'-6'-dihydroxy-4'-oxo-
cyclohex-2'-enyl)-acetonitrile are simple artifacts, as aeroplysinin-1 is able to form them in the 
presence of acetone by keto-enol tautomerism. However, these acetonitriles are not normally produced 
as metabolites of aeroplysinin-1 (XXXII) in other species [27]. 
3.11. Dibromocyclohexadienes 
This group is comprised of two substances which present a 1,2-dihydroarene-1,2-diol and may have 
their biogenesis via an arene oxide (XXXI) in agreement with their stereochemistry [94,95]. 
Aeroplysinin-1 (XXXII) is a nitrilated substance found in dextro and levorotatory forms. The 
dextrorotatory isomer (+) aeroplysinin-1, has been obtained from Aplysina aerophoba [70], Aiolocroia 
crassa, Verongula rigida, Aplysina archeri [71] and Psammoposilla purpurea [134]. (−) Aeroplysinin-1 
has been found in Ianthella ardis [135] and Verongula gigantean [71]. The metabolic degradation of 
bis-oxazolidone, isofistularin-3, aplysinamisin-1 and aerophobin-2 is known to be an important source 
of aeroplysinin-1 [13]. In terms of pharmacological activity, aeroplysinin-1 is a versatile substance 
which has demonstrated cytotoxic [134], antiprotozoal [136] and antiangiogenic [137] activities. 
Aplysifulvin is one of the most recently isolated substances from the sponge A. fulva [97]. It possesses 
only two methoxies and no ethoxies, and since no ethoxy derivatives were detected, the possibility that 
aplysifulvin is an artifact has been discarded. Hypothetically, the chemical structure of aplysifulvin 
suggests that the 3,3-dialkoxy ketals (with OMe and OEt groups) previously described are   
artifacts [97]. 
3.12. Structural Elucidation 
This section describes the compilation of the 
13C chemical shifts of halogenated compounds of the 
genus Aplysina. All compounds compiled in this review—bromotyramines (1–4), cavernicolins (5–17), 
hydroverongiaquinols (18–20), bromotyrosineketals (21–24), bromotyrosine lactone derivatives   
(25–28), oxazolidones (29–32), spiroisoxazolines (33–81), verongiabenzenoids (82–86), 
verongiaquinols (87–99) and dibromocyclohexadienes (100–101)—have in common 3,5-halotyrosine 
or halophenylalanine derivatives. 
Research data shows that works from the decades of 1970, 1980 and 1990 show little or no 
information of 
13C NMR as compounds (95–97) whose structural elucidation was done by mass 
spectrometry (MS) and 
1H NMR spectroscopy analysis and reactions of structural identification. 
The bromotyramine family skeleton can be recognized by the typical 
1H-NMR signals, as for 




triples (δ 3.02, 2H, 8.0 Hz; δ 3.50, 2H, 8.0 Hz; δ 4.12, 2H, 5.5 Hz; δ 3.22, 2H, 5.5 Hz) attributed to  
H-7, H-8, H-1’, H-3’ respectively [84]. When NH-3’ has low electron density as compound 1 
positively charged and compound 2 close to electrophilic oxime group, the 
13C-NMR signals shift to 
downfield compared to compounds 3 and 4,whose substituents are methyl groups [84]. 
Typical 
1H NMR data from the cavernicolin class are, in the case of compound 5, for H-3 δ 4.05 
(dd, J = 10.1 Hz and J = 1.5 Hz), a singlet for H-5 at δ 7.3 and the signals for NH and OH at 6.9 (s) and 
4.4 (s) respectively [83]. 
13C NMR data shows that chlorinated carbon have their signals at downfield 
shifts in relation to bromine carbons as it can be seen, for example, comparing compounds 5 and 6 
with 9 and compound 11 with 12. 
Biosynthetically, verongiaquinol metabolites are the oxidized form of hydroverongiaquinols, 
considered as a hydroquinone precursor [124,138]. Therefore, the basic difference in the 
13C NMR 
between these two classes is the downfield signal of ketone carbon C-1 (δ 172.6) of compound 91 
compared with hydroxylated C-1 (δ 150.0) of compound 20 [97]. 
Data analysis of the 
13C NMR bromotyrosine lactone family brominated aromatic show carbon 
signals have more shielded signals compared to the other aromatic signals of the ring. The more is the 
unsaturated side branching at C-7, more deshielded are the signals of the lactone ring, with the 
increasing order of introducing the compounds 28, 27 and 26 [64,109]. 
The carbons of the spiroisoxazolinic system of most compounds with cores G1, G2, G7, G8 and G9 
acquire values which become a standard set of values, with the exception of carbons C-2 and C4 
values, which seem to be mistakenly exchanged one for another at δ 120 or δ 114, being the correct 
value of δ 120 for carbon C-2 due to the proximity of the hydroxyl and the C-4 for δ 114. 
The mono and bis-spiroisoxazolinic ring systems could be distinguished by double 
1H-NMR shield 
and deshield signals for the two rings, for example, compound 50 shows signals at δ 4.16 (1H, d,  
J = 8.3 Hz) for H-1 and δ 4.58 (1H, d, J = 7.9 Hz) for H 1’. A typical methylene signal at δ 4.43; 3.47 
(2H, ABq, J = 18.2) is attributed to the isoxazol ring protons H-7, 7’ for this compound [29]. Today the 
most used techniques to elucidate absolute stereochemistry of the rings are 
1H-NMR spectrum analysis 
and molecular modeling using both MM2 and MOPAC protocols of the Chem3D software [76], and 
also NOE-difference spectroscopy studies [100]. 
13C data reveals spiroisoxazoline ring systems have distinguished shifts. The difference between 
cyclohexadienone (G1, G2, G7, G8 and G9) and cyclohexenone (G3 and G4) systems are two chemical 
shifts at downfield for C-3’ and C-5’ (54–55) and one at upfield for C-2’ in G3 (56–61), and the same 
shifts for C-3, -3', C-5, -5', C-2, -2' in G4 (56–61). The epoxide group in G5 and G6 can be characterized 
by the same shifts plus two differences: a strong shift at downfield for C-3 and C-3' in G5 and C-3' in 
G6. The other difference involves three chemical shifts at upfield for C-1, 1', C-2, 2' and C-6, 6' of 62 
and for C-1', C-2' and C-6' of 63. Some 
13C data as δ 67.2 and δ 65.7 attributed to chiral C-11 of 
compound 42 still remain with its stereochemistry unsolved [76]. 
According to Kossuga, 2004 [123], to determine the configuration of the relative stereochemistry of 
bis-oxazolidone uses [α] of (7R,11R) bis-oxazolidone with absolute stereochemistry [64]. It was 
possible to determine the relative configuration of bis-oxazolidones (7*R,11*S) and (11*R,7*S) 





The genus Aplysina is one of the richest in secondary metabolites, which have been cataloged in 14 
species from the Aplysinidae family. Most classes of compounds mentioned here present themselves 
brominated, and, despite the large number of species of the genus Aplysina, many have not been 
studied chemically. The halogenated compounds found in marine sponges of this genus were classified 
into: (A) Bromotyramines, (B) Cavernicolins, (C) Hydroverongiaquinols, (D) Bromotyrosineketals, 
(E) Bromotyrosine Lactone derivatives, (F) Oxazolidones, (G) Spiroisoxazolines,   
(H) Verongiabenzenoids, (I) Verongiaquinols and (J) Dibromocyclohexadiens. 
In view of their potential for producing new compounds of pharmacological interest, sponges have 
been one of the most studied organisms from a chemical point of view. Over the past 20 years, 
hundreds of substances have been isolated from sponges, many of which have been identified and 
show interesting biological and pharmacological activities, as for example, antibacterial, anticoagulant, 
antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, antiviral, immunosuppressive 
and neurosuppressive activities. 
The species of the genus Aplysina also show a wide structural variety of nitrogen compounds, 
present only in marine sponges. Therefore they are a rich source for research of new structural models 
for future therapeutic applications. With the information provided in this review, we hope to facilitate 
research in the field and to contribute to a better understanding and knowledge of the phytochemistry 
of this genus.  
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